Samsung Invests $2B in BiopharmaceuticalsSamsung is investing at least $2 billion in... biopharmaceuticals? With this foray into the drug industry, Samsung hopes to become a major player in biotechnology, which is expected to be a booming industry in coming years. A key component of this play is so-called biosimilars -- cheap versions of brand-name biotechnology drugs that no longer are protected by patents.
Source:
Samsung Invests $2B in Biopharmaceuticals
